Evaluation of a novel, commercially available mass spectrometry kit for newborn screening including succinylacetone without hydrazine

详细信息	查看全文 | 推荐本文 |

• 作者：Thomas F. Metz^a ; ^b ; Thomas P. Mechtler^a ; ^b ; Michael Merk^c ; Anne Gottschalk^c ; Richard Luka膷in^c ; Kurt R. Herkner^a ; ^b ; David C. Kasper^a ; ^b ; ^{david.kasper@meduniwien.ac.at}
• 关键词：Newborn screening ; Tyrosinemia type I ; Succinylacetone ; Hydrazine ; High-throughput mass spectrometry
• 刊名：Clinica Chimica Acta
• 出版年：2012
• 期刊代码：54_00098981
• 类别：med
• 出版时间：16 August, 2012
• 卷：413
• 期：15-16
• 页码：1259-1264
• 文件大小：311 K

摘要

Newborn screening for tyrosinemia type I (Tyr-I) is mandatory to identify infants at risk before life-threatening symptoms occur. The analysis of tyrosine alone is limited, and might lead to false-negative results. Consequently, the analysis of succinylacetone (SUAC) is needed. Current protocols are time-consuming, and above all, include hazardous reagents such hydrazine. We evaluated a novel, commercial kit to analyze amino acids, acylcarnitines and SUAC with a significantly less harmful hydrazine derivative in a newborn screening laboratory. Dried blood spot specimens from 4683 newborns and samples from known patients with inborn errors of metabolism (IEM) were analyzed by a novel protocol and compared to an in-house screening assay. All samples were derivatized with butanol-HCl after extraction from 1/8-inch DBS punches. For the novel protocol, the residual blood spots were extracted separately for SUAC, converted into hydrazone, combined with amino acids and acylcarnitines, and subsequently analyzed by mass spectrometry using internal isotope-labeled standards. All newborns were successfully tested, and 74 patients with IEMs including three with Tyr-I (SUAC 1.50, 4.80 and 6.49; tyrosine levels 93.10, 172.40 and 317.73, respectively) were detected accurately. The mean SUAC level in non-affected newborns was 0.68 渭mol/l (cut-off 1.29 渭mol/l). The novel assay was demonstrated to be accurate in the detection of newborns with IEM, robust, and above all, without the risk of the exposure to highly toxic reagents and requirement of additional equipment for toxic fume evacuation.